Nasal-Phyto Pharmaceutical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 2

Nasal-Phyto Pharmaceutical General Information

Description

Developer of new drugs for central nervous system (CNS) diseases. The company is committed to build new specialty drugs that include new nasal-brain delivery drug delivery technologies, formulation research and development and pilot production, and drug-device integration performance testing, providing patients with CNS diseases with safer and more effective treatment options.

Contact Information

Website
www.nasal-phyto.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 401, Building B4
  • Shencheng Investment & Zhongcheng Life Science Park, Pingshan District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 401, Building B4
  • Shencheng Investment & Zhongcheng Life Science Park, Pingshan District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nasal-Phyto Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A1) 31-May-2023 Completed Pre-Clinical Trials
2. Early Stage VC 20-Oct-2021 Completed Pre-Clinical Trials
1. Seed Round 21-Feb-2020 $2.15M $2.15M Completed Pre-Clinical Trials
To view Nasal-Phyto Pharmaceutical’s complete valuation and funding history, request access »

Nasal-Phyto Pharmaceutical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yael Capital Venture Capital Minority
Kaitai Capital Venture Capital Minority
To view Nasal-Phyto Pharmaceutical’s complete investors history, request access »

Ready to get started?

Request a free trial

Nasal-Phyto Pharmaceutical FAQs

  • When was Nasal-Phyto Pharmaceutical founded?

    Nasal-Phyto Pharmaceutical was founded in 2019.

  • Where is Nasal-Phyto Pharmaceutical headquartered?

    Nasal-Phyto Pharmaceutical is headquartered in Shenzhen, China.

  • What industry is Nasal-Phyto Pharmaceutical in?

    Nasal-Phyto Pharmaceutical’s primary industry is Drug Delivery.

  • Is Nasal-Phyto Pharmaceutical a private or public company?

    Nasal-Phyto Pharmaceutical is a Private company.

  • What is Nasal-Phyto Pharmaceutical’s current revenue?

    The current revenue for Nasal-Phyto Pharmaceutical is .

  • How much funding has Nasal-Phyto Pharmaceutical raised over time?

    Nasal-Phyto Pharmaceutical has raised $2.15M.

  • Who are Nasal-Phyto Pharmaceutical’s investors?

    Yael Capital and Kaitai Capital have invested in Nasal-Phyto Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process